Changli (David) Wei to Receptors, Urokinase Plasminogen Activator
This is a "connection" page, showing publications Changli (David) Wei has written about Receptors, Urokinase Plasminogen Activator.
Connection Strength
1.988
-
uPAR isoform 2 forms a dimer and induces severe kidney disease in mice. J Clin Invest. 2019 04 02; 129(5):1946-1959.
Score: 0.682
-
SuPAR mediates viral response proteinuria by rapidly changing podocyte function. Nat Commun. 2023 07 21; 14(1):4414.
Score: 0.230
-
Soluble Urokinase Receptor and Acute Kidney Injury. N Engl J Med. 2020 01 30; 382(5):416-426.
Score: 0.180
-
Soluble Urokinase Plasminogen Activator Receptor and Decline in Kidney Function in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2019 07; 30(7):1305-1313.
Score: 0.173
-
Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease. Nat Med. 2017 01; 23(1):100-106.
Score: 0.145
-
Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte ?3-integrin Activation. Transplantation. 2015 Dec; 99(12):2593-7.
Score: 0.135
-
Soluble Urokinase Receptor and Chronic Kidney Disease. N Engl J Med. 2015 Nov 12; 373(20):1916-25.
Score: 0.135
-
Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy. Transplantation. 2013 Oct 15; 96(7):649-56.
Score: 0.117
-
Modification of kidney barrier function by the urokinase receptor. Nat Med. 2008 Jan; 14(1):55-63.
Score: 0.078
-
The D2D3 form of uPAR acts as an immunotoxin and may cause diabetes and kidney disease. Sci Transl Med. 2023 09 20; 15(714):eabq6492.
Score: 0.058
-
suPAR links a dysregulated immune response to tissue inflammation and sepsis-induced acute kidney injury. JCI Insight. 2023 04 10; 8(7).
Score: 0.056